Cholinergic Reversal
Cholinergic Reversal is a pharmacological intervention strategy within the class of reversal agents that specifically restores neuromuscular transmission by enhancing acetylcholine availability at the synaptic cleft through inhibition of acetylcholinesterase.
122
Publications
6.1K
Citations
542
Authors
200
Institutions
Publications per year
2017–2026
16
Parents
122
Julia M. Adam, David Jonathan Bennett, A. Bom et al. · Journal of Medicinal Chemistry · 2002 · 233 citations
H. J. Sparr, Karel M. Vermeyen, Anton M. Beaufort et al. · Anesthesiology · 2007 · 214 citations · Full text
1–5 of 122
542
4
h-index
4
h-index
4
h-index
Icahn School of Medicine at Mount Sinai, United States
3 publications · 115 citations
3
h-index
3
h-index
1–5 of 542
200
Kyung Hee University
Seoul, South Korea
4 h-index
29 publications
1.4K citations

China Medical University
Taichung, Taiwan
3 h-index
6 publications
276 citations

Tel Aviv University
Tel Aviv, Israel
2 h-index
4 publications
227 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
2 h-index
4 publications
66 citations
Office of the Chief Scientist
Jerusalem, Israel
2 h-index
2 publications
459 citations
Northwest A&F University
Yangling, China
2 h-index
20 publications
584 citations
Kyushu University
Fukuoka, Japan
2 h-index
10 publications
168 citations
Queen's University Belfast
Belfast, United Kingdom
2 h-index
7 publications
154 citations
1–8 of 200
Repository · 11 publications · 163 citations
11
h-index
7 publications · 923 citations
7
h-index
BJP · 5 publications · 160 citations
5
h-index
EJA · 4 publications · 155 citations
4
h-index
3 publications · 73 citations
3
h-index
1–5